Multiple anti-tumor effects of Reparixin on thyroid cancer
Open Access
- 21 March 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (22) , 35946-35961
Abstract
Multiple anti-tumor effects of Reparixin on thyroid cancerKeywords
This publication has 40 references indexed in Scilit:
- Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modellingOncotarget, 2015
- Metformin Reverts the Secretion of CXCL8 Induced by TNF-α in Primary Cultures of Human Thyroid Cells: An Additional Indirect Anti-Tumor Effect of the DrugThe Journal of Clinical Endocrinology & Metabolism, 2015
- Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8–Akt–Slug pathwayOncogene, 2015
- Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination2014
- Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cellsOncotarget, 2014
- CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial–mesenchymal transitionCancer Letters, 2014
- Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cellsBreast Cancer Research, 2013
- PlerixaforDrugs, 2011
- Mast cells have a protumorigenic role in human thyroid cancerOncogene, 2010
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009